 |
|
A Pilot Randomized Trial of As-Needed Budesonide-Formoterol for Stepping Down Controller Treatment in Moderate Asthma with Complete Remission
Narongwit Nakwan, Thidarat Ruklerd, Pattarawadee Taptawee
Tuberc Respir Dis. 2022;85(3):227-236. Published online 2022 May 30 DOI: https://doi.org/10.4046/trd.2022.0038
|
|
Citations to this article as recorded by
 Systematic literature review of traits and outcomes reported in randomised controlled trials of asthma with regular dosing of inhaled corticosteroids with short-acting β2-agonist reliever, as-needed ICS/formoterol, or ICS/formoterol maintenance and reliev
Nicolas Roche, Arzu Yorgancıoğlu, Alvaro A. Cruz, Gabriel Garcia, Kim L. Lavoie, PG Abhijith, Manish Verma, Anurita Majumdar, Swarnendu Chatterjee
Respiratory Medicine.2024; 221: 107478. CrossRef
|